摘要
目的:分析2008—2009年解放军第一七四医院肝病专科中成药应用情况与用药变化趋势,为临床合理用药提供参考依据。方法:利用"军卫一号"信息系统数据库,检索我院肝病类中成药使用数据,对年用药金额、用药频度、日用药金额进行统计分析。结果:当飞利肝宁胶囊、护肝宁片等应用广泛,茵栀黄颗粒、澳泰乐颗粒受剂型及竞争影响,用药量下降,护肝宁片、片仔癀茵胆平肝胶囊用药量大幅上升,中成药的销售金额与DDDs同步性较好。结论:我院肝病专科口服中成药应用基本合理。
OBJECTIVE： To analyze the utilization of oral Chinese patent medicines （CPM） between 2008 and 2009 for liver disease in our hospital so as to provide scientific evidence for clinical rational administration of CPMI METHODS ： The consumption of data of CPM from 2008 to 2009 in the center of Liver disease was retrieved from ＂No. 1 military medical project＂ information system database and analyzed statistically in respect of the consumption sum, DDDs and daily drug consumption sum. RESULTS： There was a widespread application of Dangfeiliganling capsules and Huganling tablets. The consumption of Yinzhihuang and Aotaile granules witnessed a great reduction due to the effects of dosage form and fierce competition. Huganling tablets and Pianzhaihuang capsules assumed fast increase in consumption quantity. The consumption sum and DDDs of CPM showed good synchronism. CONCLUSION： The utilization of oral CPM in our hospital was basically rational.
出处
《中国医院用药评价与分析》
2010年第11期985-987,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
肝病类中成药
用药分析
日用药金额
用药频度
Chinese patent medicines for liver disease
Analysis of drug utilization
DDC
DDDs
